Effect of interferon-alfa treatment in renal transplant recipients with chronic hepatitis C. 1998

T Tokumoto, and K Tanabe, and N Ishikawa, and T Simizu, and T Oshima, and S Noguchi, and N Gouya, and H Nakazawa, and E Hashimoto, and S Fuchinoue, and N Hayashi, and H Toma
Department of Urology, Tokyo Women's Medical University, Japan.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D016898 Interferon-alpha One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways. Interferon Alfa,Interferon, Leukocyte,Interferon, Lymphoblast,alpha-Interferon,IFN-alpha D,IFN-alpha5,Interferon alpha-1,Interferon alpha-17,Interferon alpha-4,Interferon alpha-5,Interferon alpha-7,Interferon alpha-88,Interferon alpha-J,Interferon alpha-T,Interferon alpha4,Interferon alpha5,Interferon, Lymphoblastoid,Interferon, alpha,LeIF I,LeIF J,Leif D,IFN alpha D,IFN alpha5,Interferon alpha,Interferon alpha 1,Interferon alpha 17,Interferon alpha 4,Interferon alpha 5,Interferon alpha 7,Interferon alpha 88,Interferon alpha J,Interferon alpha T,Leukocyte Interferon,Lymphoblast Interferon,Lymphoblastoid Interferon,alpha Interferon

Related Publications

T Tokumoto, and K Tanabe, and N Ishikawa, and T Simizu, and T Oshima, and S Noguchi, and N Gouya, and H Nakazawa, and E Hashimoto, and S Fuchinoue, and N Hayashi, and H Toma
December 1996, Transplantation proceedings,
T Tokumoto, and K Tanabe, and N Ishikawa, and T Simizu, and T Oshima, and S Noguchi, and N Gouya, and H Nakazawa, and E Hashimoto, and S Fuchinoue, and N Hayashi, and H Toma
January 1991, The Italian journal of gastroenterology,
T Tokumoto, and K Tanabe, and N Ishikawa, and T Simizu, and T Oshima, and S Noguchi, and N Gouya, and H Nakazawa, and E Hashimoto, and S Fuchinoue, and N Hayashi, and H Toma
January 1992, The Western journal of medicine,
T Tokumoto, and K Tanabe, and N Ishikawa, and T Simizu, and T Oshima, and S Noguchi, and N Gouya, and H Nakazawa, and E Hashimoto, and S Fuchinoue, and N Hayashi, and H Toma
May 1995, Transplantation,
T Tokumoto, and K Tanabe, and N Ishikawa, and T Simizu, and T Oshima, and S Noguchi, and N Gouya, and H Nakazawa, and E Hashimoto, and S Fuchinoue, and N Hayashi, and H Toma
February 1996, Archives of disease in childhood,
T Tokumoto, and K Tanabe, and N Ishikawa, and T Simizu, and T Oshima, and S Noguchi, and N Gouya, and H Nakazawa, and E Hashimoto, and S Fuchinoue, and N Hayashi, and H Toma
April 2003, Transplantation,
T Tokumoto, and K Tanabe, and N Ishikawa, and T Simizu, and T Oshima, and S Noguchi, and N Gouya, and H Nakazawa, and E Hashimoto, and S Fuchinoue, and N Hayashi, and H Toma
March 1999, Revista espanola de enfermedades digestivas,
T Tokumoto, and K Tanabe, and N Ishikawa, and T Simizu, and T Oshima, and S Noguchi, and N Gouya, and H Nakazawa, and E Hashimoto, and S Fuchinoue, and N Hayashi, and H Toma
January 1993, Gut,
T Tokumoto, and K Tanabe, and N Ishikawa, and T Simizu, and T Oshima, and S Noguchi, and N Gouya, and H Nakazawa, and E Hashimoto, and S Fuchinoue, and N Hayashi, and H Toma
August 1994, Transplantation proceedings,
T Tokumoto, and K Tanabe, and N Ishikawa, and T Simizu, and T Oshima, and S Noguchi, and N Gouya, and H Nakazawa, and E Hashimoto, and S Fuchinoue, and N Hayashi, and H Toma
November 2004, Transplantation,
Copied contents to your clipboard!